Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

You searched for:

SCOS/NCOA 2024 The Inaugural Carolinas Cancer Conference Fri August 2 - Sun August 4, 2024 Wild Dunes Resort Isle of Palms, SC Attendee Roster First Name Last Name Title Account Name Kevin Brewer Account Executive Abbvie Felicia Hand MSL, RN, MSN, OCN Abbvie Leiza McLeod Account Executive AbbVie Jonathan Davis Account Specialist Account Specialist Kosha Parcell Operational …
Centocorrecall-9-24-2010
Lymphomas Sabarish Ayyappan MD Clinical Assistant Professor of Medicine University of Iowa Hospitals and Clinics Disclosure of Conflicts of interest Sabarish Ayyappan MD has the following financial relationships to disclose: Research Support - Genmab, Regeneron , Astrazeneca, Innate Pharmaceuticals, Beigene, Pfizer, Xencor, Roche/Genentech Consultant- Fate therapeutics, …
Immunotherapy for High-Risk and Metastatic Melanoma Immunotherapy for High-Risk and Metastatic Melanoma Timothy M. Kuzel, MD Professor of Medicine and Dermatology Feinberg School of Medicine Northwestern University Chicago ICLIO 1st Annual National Conference 10.2.15 Philadelphia, Pa. Financial Disclosures • I currently have or …
Best of ASCO-2023 Breast Cancer Praveen Vikas MD,FACP,FASCO Clinical Associate Professor University of Iowa Holden Comprehensive Cancer Center Iowa city-IA Disclosures Research payment to institution: Sanofi, Gilead Advisory/Consultancy: MJH Life sciences, Cardinal Health, GE Healthcare, Guidepoint Stocks : Moderna, BioNTech Slide credit: …
Nutrition-Optimizin-Enteral-Nutrition
FAN-Federal-Poverty-Level-Chart-2014
Clinical Update: Multiple Myeloma Peter Voorhees, M.D. Clinical Professor of Medicine Chief, Plasma Cell Disorders Division Levine Cancer Institute, Atrium Health Wake Forest University School of Medicine Disclosures • Advisory Boards: Abbvie, BMS, Janssen, Lava Therapeutics, Sanofi • Consulting: BMS, Janssen, Karyopharm, Regeneron • Research Funding (To Institution): …
PowerPoint Presentation ESHOS SABCS 2022 Review: Genomic Update Seth A. Wander, MD, PhD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital swander@mgh.harvard.edu Disclosures • Consulting/Advisory Board: Biovica, Eli Lilly,Foundation Medicine, Hologic, Pfizer, Puma Biotechnology, Veracyte • Education/Speaking: Eli Lilly, Guardant …
Immuno-Oncology Survivor Support Resources Where to find reliable information about your condition • American Cancer Society: www.cancer.org • National Cancer Institute: www.cancer.gov • American Society of Clinical Oncology: www.cancer.net • National Comprehensive Cancer Network (NCCN): www.nccn.org/patients/ • National patient advocacy organizations: [See attached for references …
Ongoing clinical trials ER+ Changes in the Treatment Landscape of HER2 Positive Breast Cancer Virginia Kaklamani, MD DSc Professor of Medicine Leader, Breast Oncology Program Disclosures • Honoraria from: Daichi, Astrazeneka, Genentech, Gilead, Novartis, Pfizer, Seagen, Lilly, Genomic Health • Grant/Research funding from: EISAI Response to Chemo in Locally …
ACCC Oncology Care Model Collaborative Workshop Friday, March 22, 2019 8:30 AM – 5:00 PM Renaissance Washington, DC Downtown Hotel – Washington, DC ---------- 8:30 – 9:00 AM Registration and Networking Breakfast 9:00 – 9:15 AM Welcome and Introductions Steve L. D’Amato, BScPharm Executive Director, New England Cancer Specialists Chair, ACCC OCM Collaborative Basit …
Day One Day Two Day Three Day Four Day One Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat …
KentuckyOne-Flowchart-LDCT-Lung-Cancer-Screening-Program-Cancer-Prevention-Services-2016
PowerPoint Presentation Evolving Treatment Paradigms for HR+ Breast Cancer: Key Updates from SABCS 2023 SCOS/NCOA Joint Conference 2024 Charlotte, South Carolina Seth A. Wander, MD, PhD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital swander@mgh.harvard.edu Disclosures • Consulting/Advisory Board: Foundation Medicine, Veracyte, …
PowerPoint Presentation Evolving Treatment Paradigms for HR+ Breast Cancer: Key Updates from SABCS 2023 SCOS/NCOA Joint Conference 2024 Charlotte, South Carolina Seth A. Wander, MD, PhD Assistant Professor of Medicine Harvard Medical School Massachusetts General Hospital swander@mgh.harvard.edu Disclosures • Consulting/Advisory Board: Foundation Medicine, Veracyte, …
Updates in Kidney and Bladder Cancers: Where we are with Immunotherapy and Precision Medicine? Bladder Cancer: An Update on Systemic Therapies and Precision Oncology April 19, 2024 LOS 4th Annual Louisiana Cancer Congress Karine Tawagi, MD Assistant Professor of Medicine, Division of Hematology/Oncology, Genitourinary Oncology | UIC Acting Program Director, Division of …
AGENDA 11:00 – 11:40 AM ACCC Radiation Oncology Pre-Conference Registration and Networking Lunch 11:40 AM – 11:45 AM Welcome and Opening Remarks Christian G. Downs, JD, MHA Executive Director Association of Community Cancer Centers Michael J. Katin, MD, FACP, FACR, FACRO President Association of Freestanding Radiation Oncology Centers 11:45 AM – 1:00 PM Legislative and Regulatory …
MSCO20_KANKEU FONKOUA.pptx Enhanced efficacy of anti-VEGFR2/taxane therapy after progression on immune checkpoint inhibition (ICI) in patients with metastatic gastroesophageal adenocarcinoma (mGEA). Lionel Kankeu Fonkoua 1, Sakti Chakrabarti 1, Mohamad B. Sonbol 2, Pashtoon M. Kasi 3, Jason S. Starr 3, Alex J. Liu 2, Melanie C. Bois 4, Henry C. Pitot 1, Chandrikha Chandrasekharan …
6:30 – 7:30 AM Registration and Networking Breakfast 7:30 – 7:40 AM Introduction and Pre-Activity Assessment 7:40 – 8:10 AM Breast Cancer Rachel Yung, MD Seattle Cancer Care Alliance 8:10 – 8:40 AM Lung Cancer Christina Baik, MD, MPH Seattle Cancer Care Alliance 8:40 – 9:10 AM Genitourinary Cancers Petros Grivas, MD, PhD Seattle Cancer …